Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus

ClinicalTrials.gov ID: NCT00003156

Public ClinicalTrials.gov record NCT00003156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 3:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Topotecan in the Treatment of Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of topotecan in treating patients with recurrent or refractory cancer of the uterus.

Study identification

NCT ID
NCT00003156
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1998 (Type not available)
Primary completion
Oct 2005 (Actual)
Completion
Not listed
Last update posted
Apr 11, 2013

Started 1998

United States locations

U.S. sites
45
U.S. states
24
U.S. cities
42
Facility City State ZIP Site status
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 —
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781 —
Community Hospital of Los Gatos Los Gatos California 95032 —
Chao Family Comprehensive Cancer Center Orange California 92868 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637 —
Indiana University Cancer Center Indianapolis Indiana 46202-5265 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Radiation Oncology Branch Bethesda Maryland 20892 —
Tufts University School of Medicine Boston Massachusetts 02111 —
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
Washington University School of Medicine St Louis Missouri 63110 —
Cancer Center of Albany Medical Center Albany New York 12208 —
State University of New York Health Science Center at Brooklyn Brooklyn New York 11203 —
North Shore University Hospital Manhasset New York 11030 —
State University of New York Health Sciences Center - Stony Brook Stony Brook New York 11790-7775 —
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157-1082 —
Barrett Cancer Center, The University Hospital Cincinnati Ohio 45219 —
Ireland Cancer Center Cleveland Ohio 44106-5065 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210 —
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190 —
CCOP - Sooner State Tulsa Oklahoma 74136 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
CCOP - MainLine Health Wynnewood Pennsylvania 19096 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
CCOP - Baptist Cancer Institute Memphis Tennessee 38117 —
Brookview Research, Inc. Nashville Tennessee 37203 —
Simmons Cancer Center - Dallas Dallas Texas 75235-9154 —
CCOP - Scott and White Hospital Temple Texas 76508 —
Fletcher Allen Health Care Burlington Vermont 05401 —
Cancer Center, University of Virginia HSC Charlottesville Virginia 22908 —
University of Washington Medical Center Seattle Washington 98195-6043 —
Tacoma General Hospital Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2013 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003156 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →